Cargando…
Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway
BACKGROUND: Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-related tumor. The role of EBV-encoding miR-BART22 is still unclear in NPC. This study aimed to identify the detailed mechanisms by which EBV-miR-BART22 functions as a tumor-promoting factor and evaluate the action of cinobufo...
Autores principales: | Liu, Yiyi, Jiang, Qingping, Liu, Xiong, Lin, Xian, Tang, ZiBo, Liu, Chen, Zhou, Jin, Zhao, Mengyang, Li, Xin, Cheng, Zhao, Li, Libo, Xie, Yingying, Liu, Zhen, Fang, Weiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838365/ https://www.ncbi.nlm.nih.gov/pubmed/31594754 http://dx.doi.org/10.1016/j.ebiom.2019.08.040 |
Ejemplares similares
-
miR-4721, Induced by EBV-miR-BART22, Targets GSK3β to Enhance the Tumorigenic Capacity of NPC through the WNT/β-catenin Pathway
por: Tang, ZiBo, et al.
Publicado: (2020) -
Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9
por: Li, YongHao, et al.
Publicado: (2019) -
Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma
por: Wu, Zhen, et al.
Publicado: (2022) -
Dissecting the regulation of EBV’s BART miRNAs in
carcinomas
por: Yang, Ya-Chun, et al.
Publicado: (2017) -
ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis
por: Hou, Rentao, et al.
Publicado: (2022)